The opioid crisis is an unprecedented national emergency. Societal costs from misuse of, addiction to, and overdose from prescription opioids, heroin, and synthetic opioids over the last 2 decades account for hundreds of thousands of deaths and billions of dollars in economic burden. States have responded with wide-ranging policies that vary substantially in their key components and the opioid-crisis aspects targeted. Even nominally identical policies, such as prescription drug monitoring programs, differ in design details across states and over time. These details matter for explaining differential results on key outcomes. Consequently, it is critical to identify the most effective policy components and how best to implement them.
This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.
Our mission to help improve policy and decisionmaking through research and analysis is enabled through our core values of quality and objectivity and our unwavering commitment to the highest level of integrity and ethical behavior. To help ensure our research and analysis are rigorous, objective, and nonpartisan, we subject our research publications to a robust and exacting quality-assurance process; avoid both the appearance and reality of financial and other conflicts of interest through staff training, project screening, and a policy of mandatory disclosure; and pursue transparency in our research engagements through our commitment to the open publication of our research findings and recommendations, disclosure of the source of funding of published research, and policies to ensure intellectual independence. For more information, visit www.rand.org/about/principles.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.